NCT03176186: An ongoing trial by Invero Pharma, Inc.
This trial is ongoing. It must report results 4 years, 8 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT03176186 |
|---|---|
| Title | XePOHCAS - Xenon by Inhalation for Post Out of Hospital Cardiac Arrest Syndrome |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 31, 2026 |
| Completion date | April 30, 2029 |
| Required reporting date | April 30, 2030, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Aug. 12, 2025 |
| Days late | None |